カテゴリ： MarketLine, ドイツ, 企業調査

Brenntag AG：企業の戦略・SWOT・財務情報

◆英語タイトル：Brenntag AG - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C3712
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：47
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：化学
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Brenntag AG – Strategy, SWOT and Corporate Finance Report
Summary

Brenntag AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Brenntag AG (Brenntag or ‘the company’) is an international distributor of specialty and industrial chemicals. The company offers business-to-business distribution solutions to its customers across the world. Brenntag offers wide portfolio of industrial and specialty chemicals, including caustic soda, sulphuric and hydrochloric acids, solvents, and packed coagulants. The company primarily purchases and stores large-scale quantities of industrial and specialty chemicals from various suppliers and repackages them into smaller quantities. The company provides value-added services including just-in-time delivery, product mixing, formulation, repackaging, inventory management, drum return handling, extensive technical support and e-commerce services. The company has presence across the Europe, North America, Latin America and Asia Pacific. Brenntag is headquartered in Mulheim an der Ruhr, Germany.

Scope

- Detailed information on Brenntag AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Brenntag AG in the form of a SWOT analysis
- An in-depth view of the business model of Brenntag AG including a breakdown and examination of key business segments
- Intelligence on Brenntag AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Brenntag AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Brenntag AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Brenntag AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Brenntag AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Brenntag AG: Company Overview 9
Brenntag AG: Overview and Key Facts 9
Brenntag AG: Overview 9
Brenntag AG: Key Facts 9
Brenntag AG: Key Employees 11
Brenntag AG: Key Employee Biographies 12
Brenntag AG: Major Products and Services 14
Brenntag AG: Company History 15
Brenntag AG: Management Statement 22
Brenntag AG: Locations and Subsidiaries 23
Brenntag AG: Key Competitors 25
Brenntag AG: Company Analysis 26
Brenntag AG: Business Description 26
Brenntag AG: SWOT Analysis 27
Brenntag AG: SWOT Overview 27
Brenntag AG: Strengths 27
Brenntag AG: Weaknesses 28
Brenntag AG: Opportunities 28
Brenntag AG: Threats 30
Brenntag AG: Corporate Financial Deals Activity 31
Brenntag AG: Financial Deals Overview 31
Brenntag AG: Targets and Partners 33
Brenntag AG: Top Deals 2014 – 2018YTD* 35
Brenntag AG: Advisors 36
Brenntag AG: Top Legal Advisors 36
Brenntag AG: Top Financial Advisors 36
Brenntag AG: Mergers and Acquisitions 37
Brenntag AG: Capital Raising 38
Brenntag AG: Recent Developments 39
Brenntag AG: News and Events Summary 39
Brenntag AG: Contracts 40
Brenntag AG: Corporate Governance 42
Brenntag AG: Financial Deals 42
Brenntag AG: Financial Performance 42
Brenntag AG: Strategy and Operations 43
Appendix 45
Contact Us 45
Methodology 45
About MarketLine 46

List of Tables
Table 1: Brenntag AG: Key Facts
Table 2: Brenntag AG: Key Employees
Table 3: Brenntag AG: Locations and Subsidiaries
Table 4: Brenntag AG: Key Competitors
Table 5: Brenntag AG: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Brenntag AG: M&A Activity by Geography (TTM*)
Table 7: Brenntag AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Brenntag AG: Targets and Partners
Table 9: Brenntag AG: Top Deals 2014 - 2018YTD*
Table 10: Brenntag AG: Legal Advisor Ranking by Value (US$m)
Table 11: Brenntag AG: Financial Advisor Ranking by Value (US$m)
Table 12: Brenntag AG: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Brenntag AG: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Brenntag AG: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Brenntag AG: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Brenntag AG: News and Events Summary
Table 17: Brenntag AG: Contracts
Table 18: Brenntag AG: Corporate Governance
Table 19: Brenntag AG: Financial Deals
Table 20: Brenntag AG: Financial Performance
Table 21: Brenntag AG: Strategy and Operations

List of Figures
Figure 1: Brenntag AG: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Brenntag AG: M&A Activity by Geography (TTM*)
Figure 3: Brenntag AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Brenntag AG: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Brenntag AG: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Brenntag AG: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Brenntag AG: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Brenntag AG：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Hitachi Chemical Co Ltd (4217)：企業の財務・戦略的SWOT分析
    Hitachi Chemical Co Ltd (4217) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Banque Cantonale de Geneve Private Banking：企業の戦略・SWOT・財務分析
    Banque Cantonale de Geneve Private Banking - Strategy, SWOT and Corporate Finance Report Summary Banque Cantonale de Geneve Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Unilife Corporation (UNIS)-医療機器分野：企業M&A・提携分析
    Summary Unilife Corporation (Unilife) is a developer and commercial supplier of injectable drug delivery systems with focus on wearable injector products. It develops, manufactures and distributes safety engineered syringes for medical device and pharmaceutical industries. The company's product port …
  • UNIQA Ukraine：企業の戦略・SWOT・財務情報
    UNIQA Ukraine - Strategy, SWOT and Corporate Finance Report Summary UNIQA Ukraine - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Compagnie Ivoirienne d’Electricite (CIEC)：企業の財務・戦略的SWOT分析
    Summary Compagnie Ivoirienne d'Electricite (CIE), a subsidiary of Eranove, is a power company that provides power generation, transmission, and distribution services. The company offers exporting, importing and marketing of electricity. It provides operation and management of hydroelectric and therm …
  • Iterum Therapeutics Plc (ITRM)：製薬・医療：M&Aディール及び事業提携情報
    Summary Iterum Therapeutics Plc (Iterum Therapeutics) is a clinical-stage pharmaceutical company which develops anti-infectives for multi-drug resistant (MDR) pathogens for treating serious and life-threatening diseases. The company is developing Sulopenem, an oral and IV targeted-spectrum penem ant …
  • Pt Bakrieland Development Tbk：企業の戦略・SWOT・財務分析
    Pt Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Astex Pharmaceuticals, Inc.：企業の戦略・SWOT・財務情報
    Astex Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Astex Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • PTT Public Co Ltd (PTT)-エネルギー分野：企業M&A・提携分析
    Summary PTT Public Company Limited (PTT) is an integrated national oil and gas, and petrochemical company. It operates in oil and natural gas, coal, power, and infrastructure businesses. The company carries out oil and natural gas exploration and production; oil refining; procurement, processing, tr …
  • Snam SpA (SRG)：電力：M&Aディール及び事業提携情報
    Summary Snam SpA (Snam) is an integrated midstream energy company. The company, through its subsidiaries, carries out the regasification, transportation, storage and supply of natural gas. It transports and dispatches natural gas through a transportation network, a dispatch center, supervisory distr …
  • Tarveda Therapeutics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Tarveda Therapeutics Inc (Tarveda), formerly Blend Therapeutics Inc is a clinical stage biopharmaceutical company that discovers and develops miniaturized novel biologic drug conjugates. The company develops targeted anti-cancer medicines for advancing the treatment for solid tumors. Its pip …
  • Eidgenossische Technische Hochschule Zurich：製薬・医療：M&Aディール及び事業提携情報
    Summary Eidgenossische Technische Hochschule Zurich (ETH Zurich) is an educational service provider that offers studies in technology and the natural sciences. The university offers scientific education through bachelor programmes and master programmes in the areas of applied geophysics, architectur …
  • Itau Unibanco Holding SA：企業の戦略・SWOT・財務情報
    Itau Unibanco Holding SA - Strategy, SWOT and Corporate Finance Report Summary Itau Unibanco Holding SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ZAPPALLAS, Inc. (3770)：企業の財務・戦略的SWOT分析
    ZAPPALLAS, Inc. (3770) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • OpGen Inc (OPGN)：製薬・医療：M&Aディール及び事業提携情報
    Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, s …
  • Cyberhawk Innovations Ltd：石油・ガス：M&Aディール及び事業提携情報
    Summary Cyberhawk Innovations Ltd (Cyberhawk), formerly Castlelaw (No.740) Ltd is an engineering company that provides aerial inspection and land surveying services. The company conducts close visual and thermal inspections of industrial assets both on- and offshore. It offers industrial inspection …
  • BFS Group Ltd：企業の戦略・SWOT・財務分析
    BFS Group Ltd - Strategy, SWOT and Corporate Finance Report Summary BFS Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Carmot Therapeutics Inc-製薬・医療分野：企業M&A・提携分析
    Summary Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company which discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company’s product portfolio encompasses investigational candidates in preclinical trials: peptide-small molecule h …
  • Lloyds Banking Group Plc：企業の戦略・SWOT・財務分析
    Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report Summary Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Celsense Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Celsense Inc (Celsense) is a biotechnology company that develops magnetic resonance imaging detection products to monitor the location and quantity of transplanted cells. The company’s products include v-sense, cell sense and voxel tracker. Its v-sense product is a reagent used to detect var …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆